The addition of β-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. This benefit had been in question ...

Chronic behavioral stress and beta-adrenergic signaling have been shown to promote cancer progression, whose underlying mechanisms are largely unclear, especially the involvement of epigenetic ...

About 25% of the African-American population carries a gene variant that seems to protect against heart failure. The findings may have implications for the use of β-blockers (pages 510–517). The ...

Please provide your email address to receive an email when new articles are posted on . CuraSen Therapeutics has announced positive data from a phase 2a study of its combination adrenergic activator, ...

ASTHMA can be defined as a disease of the bronchi producing diffuse, reversible bronchial obstruction. The bronchial tree of patients with asthma is hypersensitive to the effects of dust, cold air, ...

Noradrenaline is a neuromodulator secreted in the brain depending on behavioral context and physiological states of animal, influencing a wide range of physiological functions by modulating brain ...

Bio-miR: A prognostic microRNA-based signature for localized clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a ...

This study is led by Dr. Han Xiao (Department of cardiology and institute of vascular medicine, Peking university third hospital). Rapid over-activation of β-adrenergic receptors (β-AR) following ...

Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs. Objective: To assess whether increased short-acting ...

Researchers in Japan have discovered that the adrenergic nervous system controls when white blood cells circulate through the body, boosting the immune response by retaining T and B cells in lymph ...

Researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The study found phenylacetylglutamine (PAG), produced by gut bacteria ...